Membrane permeation mechanisms of 2′,3′-dideoxynucleosides
- 17 August 1993
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 46 (4) , 725-729
- https://doi.org/10.1016/0006-2952(93)90560-j
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Ganciclovir permeation of the human erythrocyte membraneBiochemical Pharmacology, 1991
- Cellular Pharmacology and Anti-HIV Activity of 2′,3′-DideoxyguanosineAIDS Research and Human Retroviruses, 1990
- Dideoxycytidine permeation and salvage by mouse leukemia cells and human erythrocytesBiochemical Pharmacology, 1989
- Human red blood cells as bioreactors for the release of 2′,3′-dideoxycytidine, an inhibitor of HIV infectivityBiochemical and Biophysical Research Communications, 1989
- Uptake of 2′,3′-Dideoxyadenosine in Human Immunodeficiency Virus-Infected and Noninfected Human CellsAIDS Research and Human Retroviruses, 1989
- 2′,3′-Dideoxythymidine permeation of the human erythrocyte membrane by nonfacilitated diffusionBiochemical and Biophysical Research Communications, 1988
- Initial studies on the cellular pharmacology of 2′,3′-dideoxyinosine, an inhibitor of HIV infectivityBiochemical Pharmacology, 1987
- Initial studies on the cellular pharmacology of 2′,3′-dideoxycytidine, an inhibitor of HTLV-III infectivityBiochemical Pharmacology, 1986
- Structural modifications at the 2'— and 3'— positions of some pyrimidine nucleosides as determinants of their interaction with the mouse erythrocyte nucleoside transporterBiochemical Pharmacology, 1984
- Statistical methods to distinguish competitive, noncompetitive, and uncompetitive enzyme inhibitorsAnalytical Biochemistry, 1981